Clinical Trial Update: Safety and Immunogenicity of a Group B Streptococcus Vaccine in Healthy Women [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and immunogenicity of a Group B Streptococcus vaccine in healthy women; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Group Streptococcal Infection

Drugs mentioned

• Group B Streptococcus vaccine

Snippet

Sponsor: Novartis Vaccines | Conditions: Group B Streptococcus | Phase 1 | Status: COMPLETED | Results posted: 2017-05-15